Drug intelligence / Profile preview

Indukantham Tablet

Development stage: Preclinical
Lead developer: Arya Vaidya Sala Kottakkal
Modality: Small Molecules
Administration: Oral

Overview

Indukantham Tablet is a polyherbal Ayurvedic formulation developed by Kottakkal Arya Vaidya Sala. Traditionally used in Ayurvedic medicine for its immunomodulatory and anti-pyretic properties, it is indicated for the management of fevers and the enhancement of the body's natural immune defenses. During the COVID-19 pandemic, research conducted by the Centre for Medicinal Plants Research (CMPR) identified potential anti-viral activity against SARS-CoV-2, leading to its inclusion in certain COVID-19 management protocols in India. As a traditional polyherbal preparation, its therapeutic effects are attributed to the synergistic action of its constituent herbs rather than a single defined molecular target.

Brand names: Indukantham Tablet
Other names: IndukanthamIndukantha Tablet

Beyond the preview

Go deeper on Indukantham Tablet.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Indukantham Tablet.

Explore the full profile